As many of us were recovering from the flu, AstraZeneca reported strong earnings growth in the third quarter. The company's nasal spray vaccine is in great demand as many people like me avoid needles. Investors looking for diversified exposure to the major companies that are selling high demand drugs to battle the flu should consider the IShares Global Health Care ETF (NYSEARCA:IXJ). This ETF’s top holdings include Novartis (7%), GlaxoSmithKline (5.5%) and AstraZeneca (3.4%). This ETF has moved up recently in my ETF Action ratings. For more on which ETFs have strong momentum check out the ETF Action tab at the top of the page.
To access my special Market Outlook for 2010 report, click here